ADLM Welcomes Dr. H. Timothy Hsiao as Its New Chief Scientific Officer

Dr. H. Timothy Hsiao Joins ADLM as Chief Scientific Officer

The Association for Diagnostics and Laboratory Medicine (ADLM) is thrilled to announce the appointment of Dr. H. Timothy Hsiao as its new Chief Scientific Officer, effective July 21. Dr. Hsiao joins ADLM with a wealth of experience, bringing over 15 years of expertise in steering scientific programs and strategies in various sectors, including government, nonprofit organizations, and scientific communities.

Dr. Hsiao's most recent role was as Principal Advisor and Senior Innovation Strategy and Management Advisor under an Avantiqor contract. Here, he provided critical technical assistance to the Advanced Research Projects Agency for Health. His responsibilities included advising on the development of national-scale innovation initiatives and evaluating cutting-edge technologies in advanced diagnostics and data science, such as microfluidic liquid biopsies, quantum sensing, multi-modal data integration, artificial intelligence, and quantum computing.

Previously, Dr. Hsiao held the position of Chief Scientific Officer and Head of Research Strategy and Alliances at the Solve ME/CFS Initiative. In that capacity, he was instrumental in leading scientific strategy for precision medicine, diagnostics, and clinical research concerning myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). He was also responsible for directing a real-world data platform and forging partnerships with academic institutions and industry leaders.

In an earlier career phase, Dr. Hsiao was the Director of Scientific Affairs at the American Society for Radiation Oncology. He successfully led scientific programming and research partnerships there. He has also worked at the National Institutes of Health (NIH) in several roles, including as Program Director at the National Center for Advancing Translational Sciences. In this role, he managed approximately $50 million in federal investments, aimed at supporting clinical and translational research infrastructure as well as workforce development.

Dr. Hsiao holds a PhD in Molecular Biophysics and Biochemistry from Yale University, an MSc in Biochemical Research from Imperial College London, and a BSc from National Chung-Hsing University.

As Chief Scientific Officer at ADLM, Dr. Hsiao will play a significant part in the executive leadership team, overseeing the association's scientific strategy, programs, and partnerships. He will collaborate closely with ADLM's volunteers, members, and staff to bolster the scientific agenda of the association, enhance education in emerging areas of laboratory medicine, and translate advancements in diagnostics and data science into practical programs aimed at improving patient care.

ADLM CEO Melanie J. Wells expressed enthusiasm about Dr. Hsiao's appointment. "Dr. Hsiao brings the scientific depth and strategic experience that ADLM needs at a time when data science and new diagnostic technologies are reshaping laboratory medicine," she stated. Her confidence in Dr. Hsiao stems from his proven track record of building successful partnerships across government, academia, industry, and nonprofit sectors.

Dr. Hsiao himself commented on his new role, emphasizing the importance of ADLM's members in the future of healthcare. He noted, "ADLM's members are central to the future of healthcare because they generate the evidence, insight, and expertise that clinicians and patients rely on every day. I am honored to join ADLM and look forward to working with its members, volunteer leaders, and staff to advance scientific programs that connect laboratory innovation with real-world impact for patients and the public."

The Association for Diagnostics and Laboratory Medicine is dedicated to improving health outcomes through laboratory medicine, uniting over 70,000 clinical laboratory professionals, physicians, researchers, and business leaders from 110 countries worldwide. Since its inception in 1948, ADLM has championed advancements in laboratory medicine through fostering scientific collaboration and knowledge sharing.

For more details about ADLM and its initiatives, visit www.myadlm.org.